Timing of ctDNA Testing in Advanced Breast Cancer

Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

NCT03709134 ·Status: COMPLETED

ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC

NCT07332975 ·Status: RECRUITING

Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer

NCT05058183 ·Status: RECRUITING ·Phase: NA

Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

NCT03786575 ·Status: UNKNOWN ·Phase: NA

Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer

NCT05945290 ·Status: COMPLETED

Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica

NCT04163159 ·Status: UNKNOWN

ctDNA Screening in Advanced HER2 Positive Gastric Cancer

NCT04520295 ·Status: UNKNOWN

ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies

NCT04265937 ·Status: RECRUITING

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

NCT01839045 ·Status: UNKNOWN

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

NCT01334021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

NCT03480659 ·Status: TERMINATED

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

NCT00601406 ·Status: UNKNOWN ·Phase: NA

Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer

NCT03161834 ·Status: WITHDRAWN

Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer

NCT04131933 ·Status: COMPLETED

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

NCT07475923 ·Status: WITHDRAWN

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

NCT05814224 ·Status: UNKNOWN ·Phase: NA

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

NCT04002986 ·Status: COMPLETED ·Phase: NA

The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients

NCT02669745 ·Status: COMPLETED

DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

NCT00899548 ·Status: COMPLETED

Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer

NCT05602831 ·Status: UNKNOWN

Prognostic and Predictive Role of Intrinsic Molecular Subtypes in BRCA-associated Breast Cancer

NCT07617025 ·Status: RECRUITING

Exploring a Breast Cancer Early Screening Model Based on cfDNA

NCT06016790 ·Status: COMPLETED

Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer

NCT00766454 ·Status: COMPLETED

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

NCT07025785 ·Status: RECRUITING ·Phase: NA

Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer

NCT02610218 ·Status: UNKNOWN